These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23703673)

  • 1. Polo-like kinase 2 is a mediator of hedgehog survival signaling in cholangiocarcinoma.
    Fingas CD; Mertens JC; Razumilava N; Sydor S; Bronk SF; Christensen JD; Ilyas SI; Canbay A; Treckmann JW; Paul A; Sirica AE; Gores GJ
    Hepatology; 2013 Oct; 58(4):1362-74. PubMed ID: 23703673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cells.
    Fingas CD; Bronk SF; Werneburg NW; Mott JL; Guicciardi ME; Cazanave SC; Mertens JC; Sirica AE; Gores GJ
    Hepatology; 2011 Dec; 54(6):2076-88. PubMed ID: 22038837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polo-like kinase 3 is associated with improved overall survival in cholangiocarcinoma.
    Juntermanns B; Sydor S; Kaiser GM; Jaradat D; Mertens JC; Sotiropoulos GC; Swoboda S; Neuhaus JP; Meng W; Mathé Z; Baba HA; Canbay A; Paul A; Fingas CD
    Liver Int; 2015 Nov; 35(11):2448-57. PubMed ID: 25818805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells.
    Sydor S; Jafoui S; Wingerter L; Swoboda S; Mertens JC; Gerken G; Canbay A; Paul A; Fingas CD
    World J Gastroenterol; 2017 Jun; 23(22):4007-4015. PubMed ID: 28652654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A smac mimetic reduces TNF related apoptosis inducing ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells.
    Fingas CD; Blechacz BR; Smoot RL; Guicciardi ME; Mott J; Bronk SF; Werneburg NW; Sirica AE; Gores GJ
    Hepatology; 2010 Aug; 52(2):550-61. PubMed ID: 20683954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting PDGFR-β in Cholangiocarcinoma.
    Fingas CD; Mertens JC; Razumilava N; Bronk SF; Sirica AE; Gores GJ
    Liver Int; 2012 Mar; 32(3):400-9. PubMed ID: 22133064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-canonical Hedgehog signaling contributes to chemotaxis in cholangiocarcinoma.
    Razumilava N; Gradilone SA; Smoot RL; Mertens JC; Bronk SF; Sirica AE; Gores GJ
    J Hepatol; 2014 Mar; 60(3):599-605. PubMed ID: 24239776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2.
    Blechacz BR; Smoot RL; Bronk SF; Werneburg NW; Sirica AE; Gores GJ
    Hepatology; 2009 Dec; 50(6):1861-70. PubMed ID: 19821497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BI6727 and GSK461364A, potent PLK1 inhibitors induce G2/M arrest and apoptosis against cholangiocarcinoma cell lines.
    Riantana H; Waenphimai O; Mahalapbutr P; Karnchanapandh K; Vaeteewoottacharn K; Wongkham S; Sawanyawisuth K
    Pathol Res Pract; 2023 Aug; 248():154678. PubMed ID: 37454493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
    Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
    Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells.
    Jinawath A; Akiyama Y; Sripa B; Yuasa Y
    J Cancer Res Clin Oncol; 2007 Apr; 133(4):271-8. PubMed ID: 17294242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma.
    Cadamuro M; Nardo G; Indraccolo S; Dall'olmo L; Sambado L; Moserle L; Franceschet I; Colledan M; Massani M; Stecca T; Bassi N; Morton S; Spirli C; Fiorotto R; Fabris L; Strazzabosco M
    Hepatology; 2013 Sep; 58(3):1042-53. PubMed ID: 23505219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hedgehog signaling between cancer cells and hepatic stellate cells in promoting cholangiocarcinoma.
    Kim Y; Kim MO; Shin JS; Park SH; Kim SB; Kim J; Park SC; Han CJ; Ryu JK; Yoon YB; Kim YT
    Ann Surg Oncol; 2014 Aug; 21(8):2684-98. PubMed ID: 24682719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells.
    Kobayashi S; Werneburg NW; Bronk SF; Kaufmann SH; Gores GJ
    Gastroenterology; 2005 Jun; 128(7):2054-65. PubMed ID: 15940637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome inhibition-induces endoplasmic reticulum dysfunction and cell death of human cholangiocarcinoma cells.
    Ustundag Y; Bronk SF; Gores GJ
    World J Gastroenterol; 2007 Feb; 13(6):851-7. PubMed ID: 17352013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma.
    Lomphithak T; Choksi S; Mutirangura A; Tohtong R; Tencomnao T; Usubuchi H; Unno M; Sasano H; Jitkaew S
    Cell Commun Signal; 2020 Oct; 18(1):161. PubMed ID: 33036630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BH3-only protein mimetic obatoclax sensitizes cholangiocarcinoma cells to Apo2L/TRAIL-induced apoptosis.
    Mott JL; Bronk SF; Mesa RA; Kaufmann SH; Gores GJ
    Mol Cancer Ther; 2008 Aug; 7(8):2339-47. PubMed ID: 18723481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequentially targeting and intervening mutual Polo-like Kinase 1 on CAFs and tumor cells by dual targeting nano-platform for cholangiocarcinoma treatment.
    Zhou Y; Xu L; Wang Z; Liu H; Zhang X; Shu C; Zhang M; Wang T; Xu X; Pu X; He J; Wang P; Qiu Y; Xu G; Zou X; Zhu Y; Wang L
    Theranostics; 2022; 12(8):3911-3927. PubMed ID: 35664077
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
    Ewald F; Grabinski N; Grottke A; Windhorst S; Nörz D; Carstensen L; Staufer K; Hofmann BT; Diehl F; David K; Schumacher U; Nashan B; Jücker M
    Int J Cancer; 2013 Nov; 133(9):2065-76. PubMed ID: 23588885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.